Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease

OBJECTIVE: Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a high risk of bleeding. We sought to develop and va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Masanobu, Kaikita, Koichi, Yasuda, Satoshi, Akao, Masaharu, Ako, Junya, Matoba, Tetsuya, Nakamura, Masato, Miyauchi, Katsumi, Hagiwara, Nobuhisa, Kimura, Kazuo, Hirayama, Atsushi, Nishihara, Eiichiro, Nakamura, Shinichiro, Matsui, Kunihiko, Ogawa, Hisao, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186465/
https://www.ncbi.nlm.nih.gov/pubmed/37173099
http://dx.doi.org/10.1136/openhrt-2023-002292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186465/
https://www.ncbi.nlm.nih.gov/pubmed/37173099
http://dx.doi.org/10.1136/openhrt-2023-002292

Ejemplares similares